The case-control study is being used increasingly to evaluate cancer risks of common genetic variants. It is commonplace for detailed information on family history of disease to be collected in these studies. The rationale for this investigation is the belief that these data on family history are not utilized efficiently by investigators. Data on the family history of first degree relatives can be assembled in a retrospective """"""""kin-cohort"""""""", and analyzed using cohort-study methodology, whereby the incident rates of the cancer under study in relatives of gene """"""""carriers"""""""" are compared with the rates in relatives of """"""""non-carriers"""""""". In this application we show that the rate ratio from a kin-cohort analysis of this nature can be expressed as a function of the rate ratio of interest (i.e. the parameter that is directly estimated in the case-control study). Thus the kin-cohort analysis can be used, in principle, as an independent verification of any genetic associations observed in the case-control study. We present evidence to suggest that the kin-cohort might have good statistical power for this purpose for the study of common cancers. In this application we plan to study in detail the statistical power of the kin-cohort analysis relative to that of the case-control study from which the data for the kin-cohort are derived. We will examine the relative efficiency of the kin-cohort analysis in relation to the underlying incidence rate of the cancer under study, the population frequency and the relative risk of the genotype. The method will also be extended to the study of the joint effect of two genotypes, and the evaluation of haplotypes. It is anticipated that the project will demonstrate that for commonly occurring cancers the kin-cohort analysis can provide an immediate independent confirmation (or refutation) of genetic associations that are observed serendipitously in case-control studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA103394-02
Application #
6790529
Study Section
Special Emphasis Panel (ZCA1-SRRB-Q (M1))
Program Officer
Mikhail, Isis S
Project Start
2003-09-01
Project End
2006-08-31
Budget Start
2004-09-01
Budget End
2006-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$84,250
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Peterlongo, Paolo; Mitra, Nandita; Sanchez de Abajo, Ana et al. (2006) Increased frequency of disease-causing MYH mutations in colon cancer families. Carcinogenesis 27:2243-9
Ellis, Nathan A; Kirchhoff, Tomas; Mitra, Nandita et al. (2006) Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genet Epidemiol 30:48-61
Purdue, Mark P; From, Lynn; Armstrong, Bruce K et al. (2005) Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 14:2015-22
Peterlongo, Paolo; Mitra, Nandita; Chuai, Shaokun et al. (2005) Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer 114:505-7
Purdue, Mark P; From, Lynn; Kahn, Harriette J et al. (2005) Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma. Int J Cancer 117:486-93
Begg, Colin B; Hummer, Amanda; Mujumdar, Urvi et al. (2004) Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 15:957-65
Mitra, Nandita; Ye, Tian-Zhang; Smith, Alex et al. (2004) Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping. Cancer Res 64:8116-25